Skip to main content

Table 5 Serum concentrations of IL-6 and TGF-β1 in patients with prostate cancer before radiotherapy and after the 25th radiotherapy fraction

From: Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms

Cytokine

Before radiotherapy

After the 25th radiotherapy fraction

p

 

Concentration [pg/mL] median (minimum–maximum)

IL-6

4.6 (0.8–41.7)

6.3 (2.3–49.3)

 < 0.001

TGF-β1

9152.8 (1600.3–37,421.8)

8104.4 (2465.1–20,718.9)

0.136